Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

European Study to Describe Hospital Stay in Patients Admitted for Acute Bipolar Manic Episodes Treated With Immediate Release Quetiapine or Extended Release Quetiapine

NCT01239589 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01239589
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01239589 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
European Study to Describe Hospital Stay in Patients Admitted for Acute Bipolar Manic Episodes Treated With Immediate Release Quetiapine or Extended Release Quetiapine
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
November 30, 2010
Completion date
March 31, 2011
Enrollment
1,280 (actual)
Sites
86

Conditions

As the registry lists them; a condition with its own page is linked.

acute bipolar manic episode